3 results
Using a single formulation of PfPEBS LSP administered at two different doses, one of 5*g and the other one of 30*g, both adjuvanted with aluminium hydroxide, in two immunizations at 28 days interval, to evaluate a) the safety and immunogenicity (…
Primary Objective: To study feasibility of a novel Splendor-X SMART system platform for hair removal treatment for all skin types. Secondary Objectives: To study efficacy and safety of the Splendor-X SMART system for hair removal treatment for all…
The purpose of this study is to understand if a new treatment for prostate cancer (niraparib) added to a standard treatment (abiraterone acetate plus prednisone) will work better than the standard treatment alone.Cohort 3: the purpose is to evaluate…